Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Ras Gene02:38

The Ras Gene

6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urolithin A activates mitophagy via the AMPK-mTOR axis and modulates the gut-ceramide axis to ameliorate cardiac remodeling in HFpEF.

Experimental & molecular medicine·2026
Same author

Effectiveness of the dual teachers-three rings-four dimensions teaching model in cultivating nursing students' comprehensive competence: A quasi-experimental study.

Nurse education today·2026
Same author

Glucocorticoid and mitophagy signaling-based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinoma.

NPJ precision oncology·2026
Same author

A virtual water-driven model for tracing environmental burden transfers through the multi-element nexus in the Pearl River Delta, China.

Journal of environmental management·2026
Same author

Nuclear Enlargement as a Histological Hallmark of Skeletal Muscle Aging, Revealed by Deep Learning-Driven Analysis and Validated in Inflammatory Myopathies.

Aging cell·2026
Same author

Shear-Stiffening Damping Ionogels Enabled by the Synergy of Dynamic Bonds and Steric Hindrance.

Advanced materials (Deerfield Beach, Fla.)·2026

Related Experiment Video

Updated: Jun 18, 2025

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

22.4K

KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression.

Young Hoon Jung1,2,3, Yun Ji Lee1,2,3, Tam Dao4

  • 1Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea.

Clinical and Molecular Hepatology
|August 4, 2024
PubMed
Summary

Potassium channel tetramerization domain containing 17 (KCTD17) protein promotes hepatocellular carcinoma (HCC) by stabilizing Ras. Inhibiting KCTD17 with antisense oligonucleotides reduced tumor growth in mice, suggesting KCTD17 as a potential HCC therapeutic target.

Keywords:
Antisense oligonucleotidesHCCKCTD17Lztr1Ras

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Related Experiment Videos

Last Updated: Jun 18, 2025

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

22.4K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Potassium channel tetramerization domain containing 17 (KCTD17) is an adaptor for the cullin3 (Cul3) ubiquitin ligase complex.
  • KCTD17's role in hepatocellular carcinoma (HCC) pathogenesis is not well understood.
  • This study investigates KCTD17's clinical features and mechanistic impact on HCC progression.

Purpose of the Study:

  • To elucidate the clinical features of KCTD17 in HCC.
  • To investigate the molecular mechanisms by which KCTD17 influences HCC progression.
  • To evaluate KCTD17-directed therapies for HCC.

Main Methods:

  • Analysis of transcriptomic data from HCC patients.
  • Assessment of HCC progression in hepatocyte-specific KCTD17 deficient mice treated with diethylnitrosamine (DEN).
  • In vivo testing of KCTD17-directed antisense oligonucleotides (ASO) in a mouse model of HCC.

Main Results:

  • KCTD17 expression is upregulated in HCC tumors and mouse models.
  • KCTD17 targets leucine zipper-like transcriptional regulator 1 (Lztr1) for degradation, stabilizing Ras and promoting liver cancer cell proliferation, migration, and wound healing.
  • KCTD17 deficiency or ASO treatment reduced HCC carcinogenesis, tumor growth, and Ras protein levels.

Conclusions:

  • KCTD17 stabilizes Ras and downstream signaling pathways, driving HCC progression.
  • KCTD17 represents a potential novel therapeutic target for hepatocellular carcinoma.
  • Targeting KCTD17 with ASOs demonstrates therapeutic potential in preclinical HCC models.